AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Methylphenidate Hydrochloride in South Africa
47 products registered with SAHPRA — 32 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LINTIRAL | 60/1.2/0090 | Biotech Laboratories (Pty) Ltd | active | 21 Jan 2030 |
| PHENITAB 54 | 56/1.2/0590 | Activo Health (Pty) Ltd | active | 12 Sept 2028 |
| PHENITAB 18 | 56/1.2/0587 | Activo Health (Pty) Ltd | active | 12 Sept 2028 |
| PHENITAB 27 | 56/1.2/0588 | Activo Health (Pty) Ltd | active | 12 Sept 2028 |
| PHENITAB 36 | 56/1.2/0589 | Activo Health (Pty) Ltd | active | 12 Sept 2028 |
| ATEROCON LA 30 mg | 54/1.2/0433 | Austell Pharmaceuticals (Pty) Ltd | active | 30 May 2028 |
| ATEROCON LA 40 mg | 54/1.2/0434 | Austell Pharmaceuticals (Pty) Ltd | active | 30 May 2028 |
| ATEROCON LA 60 mg | 54/1.2/0435 | Austell Pharmaceuticals (Pty) Ltd | active | 30 May 2028 |
| ATEROCON LA 20 mg | 54/1.2/0432 | Austell Pharmaceuticals (Pty) Ltd | active | 30 May 2028 |
| CONUFEN 27 | 56/1.2/0802 | Sandoz South Africa (Pty) Ltd | active | 24 Jan 2028 |
| CONUFEN 36 | 56/1.2/0803 | Sandoz South Africa (Pty) Ltd | active | 24 Jan 2028 |
| CONUFEN 54 | 56/1.2/0804 | Sandoz South Africa (Pty) Ltd | active | 24 Jan 2028 |
| CONUFEN 18 | 56/1.2/0801 | Sandoz South Africa (Pty) Ltd | active | 24 Jan 2028 |
| NEUTIF 54 | 55/1.2/0819 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| SATEFIN 54 | 55/1.2/0823.819 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| METHEYLPHENIDATE 27 SUN | 55/1.2/0825.817 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| NEUTIF 18 | 55/1.2/0816 | Ranbaxy Pharmaceuticals (Pty) Ltd | suspended | 25 Sept 2025 |
| NEUTIF 27 | 55/1.2/0817 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| SATEFIN 36 | 55/1.2/0822.818 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| METHEYLPHENIDATE 36 SUN | 55/1.2/0826.818 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| SATEFIN 18 | 55/1.2/0820.816 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| SATEFIN 27 | 55/1.2/0821.817 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| METHEYLPHENIDATE 18 SUN | 55/1.2/0824.816 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| METHEYLPHENIDATE 54 SUN | 55/1.2/0827.819 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| NEUTIF 36 | 55/1.2/0818 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 25 Sept 2025 |
| RALITIN 5 | 33/1.2/0439 | TRIOMED (PTY) LTD | suspended | 21 Dec 2023 |
| RALITIN 10 | 33/1.2/0440 | TRIOMED (PTY) LTD | suspended | 21 Dec 2023 |
| RALITIN 20 | 33/1.2/0441 | TRIOMED (PTY) LTD | suspended | 21 Dec 2023 |
| RITALIN 10 | B/1.2/1610 | Novartis South Africa (Pty) Ltd | active | 14 Oct 2002 |
| NEUCON 36 mg | 46/1.2/0382 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| CONCERTA 27 mg | 42/1.2/0282 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| NEUCON 18 mg | 46/1.2/0380 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| NEUCON 27 mg | 46/1.2/0381 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| RITALIN LA 40 | 36/1.2/0188 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CONCERTA 54 mg | 37/1.2/0324 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| CONTRAMYL XR 54 mg | 49/1.2/1140 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CONTRAMYL XR 36 mg | 49/1.2/1139 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| RITALIN LA 30 | 36/1.2/0187 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CONTRAMYL XR 18 mg | 49/1.2/1137 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| RITALIN LA 10 | 44/1.2/0594 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| RITALIN LA 20 | 36/1.2/0186 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CONTRAMYL XR 27 mg | 49/1.2/1138 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| CONCERTA 36 mg | 37/1.2/0323 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| CONCERTA 18 mg | 37/1.2/0322 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| NEUCON 54 mg | 46/1.2/0383 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
| METHYLPHENIDATE HCl - DOUGLAS 10 mg | 36/1.2/0234 | ACINO PHARMA (PTY) LTD | active | 1 Jan 1900 |
| ADAPHEN 10 | 33/1.2/0443 | TRIOMED (PTY) LTD | active | 1 Jan 1900 |
Methylphenidate Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 47 registered products containing Methylphenidate Hydrochloride, of which 32 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Methylphenidate Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.